Major Milestone For Diurnal As FDA Approves Alkindi

Partner Eton Predicts $100m Sales For Adrenal Insufficiency Drug

Independence day
Diurnal celebrating after US approval of Alkindi • Source: Shutterstock

More from New Products

More from Scrip